Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

Caring for Your Mental Health During Cancer Care

Hearing the words “you have cancer” can feel like the ground has shifted beneath you. Even before treatment begins, many people experience fear, w...

Read More

IN THE NEWS - PATHFINDER Study: 4-Year Safety of Avapritinib for Patients with Advanced Systemic Mastocytosis

MD/alert Suresh Balasubramanian, M.D. , hematologist and medical oncologist, and member of the  Hematology Oncology  and  Multiple ...

Read More

IN THE NEWS – Anticipatory Grief: Understanding and Coping for Patients and Caregivers

Patient Power What is anticipatory grief? It’s grief that can occur before the loss of a loved one. Mary Morreale, M.D. , clinical psychiatrist an...

Read More
News

WWJ | What You May Not Know About HPV and Cervical Cancer Screening

Listen Now

94.7 WCSX | Cervical Cancer Awareness Month

Listen Now

WSGW | Risks of Pancreatic Cancer

Listen Now